Dr. Yara Abdou, MD
Claim this profileUniversity of North Carolina at Chapel Hill
Area of expertise
Breast Cancer
Yara Abdou, MD has run 4 trials for Breast Cancer. Some of their research focus areas include:
Breast Cancer
Yara Abdou, MD has run 2 trials for Breast cancer. Some of their research focus areas include:
Affiliated Hospitals
University Of North Carolina At Chapel Hill
UNC Lineberger Comprehensive Cancer Center
Clinical Trials Yara Abdou, MD is currently running
Sacituzumab Govitecan + Pembrolizumab
for Triple Negative Breast Cancer
This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative breast cancer (TNBC) that has spread, or metastasized, to other parts the body and is PD-L1-negative. The names of the study interventions involved in this study are: * Sacituzumab govitecan (Trodelvy™;IMMU-132) * Pembrolizumab (Keytruda®; MK-3475)
Recruiting
1 award
Phase 2
15 criteria
Hormone Therapy
for Male Breast Cancer
This research study is looking to see how well male breast cancer responds to preoperative treatment with endocrine therapy and which endocrine therapy regimen is the most effective treatment for male breast cancer. The drugs used in this study are: * Tamoxifen * Anastrozole * Degarelix * Abemaciclib
Recruiting
1 award
Phase 2
12 criteria
More about Yara Abdou, MD
Clinical Trial Related
5 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Yara Abdou, MD has experience with
- Avelumab
- Sacituzumab Govitecan
- Fulvestrant
- Palbociclib
- Abemaciclib
- Anastrozole
Breakdown of trials Yara Abdou, MD has run
Breast Cancer
Breast cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Yara Abdou, MD specialize in?
Yara Abdou, MD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 negative.
Is Yara Abdou, MD currently recruiting for clinical trials?
Yes, Yara Abdou, MD is currently recruiting for 3 clinical trials in Chapel Hill North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Yara Abdou, MD has studied deeply?
Yes, Yara Abdou, MD has studied treatments such as Avelumab, Sacituzumab Govitecan, Fulvestrant.
What is the best way to schedule an appointment with Yara Abdou, MD?
Apply for one of the trials that Yara Abdou, MD is conducting.
What is the office address of Yara Abdou, MD?
The office of Yara Abdou, MD is located at: University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 United States. This is the address for their practice at the University of North Carolina at Chapel Hill.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.